|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date19 Dec 1978 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with InhaTarget Therapeutics SRL
0 Patents (Medical) associated with InhaTarget Therapeutics SRL
100 Deals associated with InhaTarget Therapeutics SRL
100 Translational Medicine associated with InhaTarget Therapeutics SRL